Matches in Nanopublications for { ?s ?p "DDI between Estrone and Tipranavir - Estropipate may increase the adverse dermatological effects (i.e. skin rash) of Tipranavir. Tipranavir may decrease the serum concentration Estropipate. Monitor for estrogen deficiency during concomitant therapy. [drugbank_resource:DB00655_DB00932]"@en ?g. }
Showing items 1 to 1 of
1
with 100 items per page.
- drugbank_resource:DB00655_DB00932 label "DDI between Estrone and Tipranavir - Estropipate may increase the adverse dermatological effects (i.e. skin rash) of Tipranavir. Tipranavir may decrease the serum concentration Estropipate. Monitor for estrogen deficiency during concomitant therapy. [drugbank_resource:DB00655_DB00932]" assertion.